Thomas K. Morgan

Rational design of 4-[(methylsulfonyl)amino]benzamides as class III antiarrhythmic agents

William C. Lumma, Ronald A. Wohl, David D. Davey et al. · Journal of Medicinal Chemistry · 1987 · 39 citations

Combinatorial Chemistry, Therapeutic Drug Monitoring, Medicinal Chemistry +15

Phase transition in a lipid bilayer. II. Influence of adamantane derivatives

Mahendra Kumar Jain, Nora Yen-Min Wu, Thomas K. Morgan et al. · Chemistry and Physics of Lipids · 1976 · 27 citations

Proteinlipid Interaction, Lipid Bilayer, Adamantane Derivatives +4

The role of intramolecular hydrogen bonding as a determinant of the conformational profiles of cGMP and cAMP

Sid Topiol, Thomas K. Morgan, Michael Sabio et al. · Journal of the American Chemical Society · 1990 · 26 citations

Conformational Profiles, Engineering, Chemical Analysis +16

Synthesis and antiarrhythmic activity of novel 3-alkyl-1-[.omega.-[4-[(alkylsulfonyl)amino]phenyl]-.omega.-hydroxyalkyl]-1H-imidazolium salts and related compounds

Randall Lis, Thomas K. Morgan, Robert J. DeVita et al. · Journal of Medicinal Chemistry · 1987 · 20 citations · Full text

Synthesis and cardiac electrophysiological activity of N-substituted-4-(1H-imidazol-1-yl)benzamides - new selective class III agents

Thomas K. Morgan, Randall Lis, William C. Lumma et al. · Journal of Medicinal Chemistry · 1990 · 20 citations

K. Morgan Jr., Molecular Pharmacology, Diversity Oriented Synthesis +13